In Memoriam: Rick Jobus, Feb. 6, 1958-June 19, 2022
Courtesy of Rick Jobus It is with deep sadness that we inform the ALS News Today community of the…
Bionews, the owner and publisher of this site, employs science writers and editors, most of whom have PhDs in the life sciences, as well as veteran journalists, who ensure stories are well-written and easy to understand. Our stories undergo a comprehensive fact-checking and editing process to confirm accuracy, objectiveness, and thoroughness in order to best serve our audience of patients and caregivers.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Courtesy of Rick Jobus It is with deep sadness that we inform the ALS News Today community of the…
FFF Enterprises and Bionews announced today that both rare and orphan disease advocates are joining forces to provide patients with…
Amyotrophic lateral sclerosis (ALS) patients with locked-in syndrome reported having a satisfactory quality of life and low levels of depression,…
Pivotal Phase 3 clinical trial results presented at this year’s 28th International Symposium on ALS/MNDÂ reveal that Cytokinetics‘ investigational…
Active Biotech, a Sweden-based biopharmaceutical company that is developing therapies for autoimmune diseases, inflammatory diseases, and cancers, recently announced that…